Publications

Detailed Information

CHEMOTHERAPY-ASSOCIATED HEPATOPATHY IN COLORECTAL CANCER LIVER METASTASIS PATIENTS

DC Field Value Language
dc.contributor.authorNam, S. J.-
dc.contributor.authorKim, H.-
dc.contributor.authorCho, J. Y.-
dc.contributor.authorLee, H. E.-
dc.contributor.authorJang, J. J.-
dc.contributor.authorChoe, G.-
dc.contributor.authorLee, H. S.-
dc.date.accessioned2012-06-28T05:34:54Z-
dc.date.available2012-06-28T05:34:54Z-
dc.date.issued2010-04-
dc.identifier.citationJOURNAL OF HEPATOLOGY; Vol.52 ; S443-S443ko_KR
dc.identifier.issn0168-8278-
dc.identifier.urihttps://hdl.handle.net/10371/77763-
dc.description.abstractBackground and Aims: Oxaliplatin, irinotecan and 5-fluorouracil
(5-FU)-based preoperative chemotherapy is increasingly used in
patients with colorectal cancer liver metastases (CRLM). Although
chemotherapy-related hepatopathy (CAH) has been described,
its impact on postoperative outcome remains controversial. The
purpose of our study was to review the effects of preoperative
chemotherapy in CRLM patients on liver histology and on
postoperative outcome.
ko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER SCIENCE BVko_KR
dc.titleCHEMOTHERAPY-ASSOCIATED HEPATOPATHY IN COLORECTAL CANCER LIVER METASTASIS PATIENTSko_KR
dc.typeConference Paperko_KR
dc.citation.journaltitleJOURNAL OF HEPATOLOGY-
dc.description.tc0-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share